Skip to content

Small Intestinal Bacterial Overgrowth: A Prospective Registry

Small Intestinal Bacterial Overgrowth: A Prospective Registry

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01822470
Acronym
SIBO
Enrollment
200
Registered
2013-04-02
Start date
2013-01-07
Completion date
2026-12-01
Last updated
2026-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Dyspepsia, Small Intestinal Bacterial Overgrowth

Keywords

functional dyspepsia, post prandial distress syndrome, small bowel bacteria overgrowth, epigastric pain syndrome, diarrhea, bloating, post prandial fullness, weight loss

Brief summary

The purpose of this study is to investigate the prevalence of small intestinal bacterial overgrowth (SIBO) in patients who will be undergoing an enteroscopy as an outpatient procedure with symptoms of functional dyspepsia. In addition, the investigators would like to identify the types of bacteria that are present in the small intestines in patients with SIBO and compare two different diagnostic tools: microbiologic culture and DNA sequencing of bacteria. The aim is to compare the microbiota between patients with and without the clinical complications of SIBO

Detailed description

Same as above

Interventions

None listed

Sponsors

Indiana University
Lead SponsorOTHER
Progenity, Inc.
CollaboratorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1.Study Subjects Inclusion Criteria i. All patients who are undergoing small bowel aspiration for suspected SIBO regardless etiology.

Exclusion criteria

i. Use of colon cleansing prep in the past 1 month ii. Treatment with antibiotics in the past 30 days (antibiotics are allowable for patients undergoing clinical indicated repeat aspiration to determine bacteria clearance) iii. Use of probiotics in the past 30 days iv. Contraindication for upper endoscopy for any reason v. Prisoners vi. Pregnant vii. Unable to give own informed consent 2 Control Subjects Inclusion Criteria i. Patients who are undergoing double balloon enteroscopy or upper enteroscopy for another medical reason.

Design outcomes

Primary

MeasureTime frameDescription
To determine the predictors for SIBO in patients with functional dyspepsia, who do not have the established risk factors for SIBOtwo yearsIn this population, prevalence of potential predictors of SIBO will be compared between subjects with and without a diagnosis of Gram Negative Bacteria SIBO

Secondary

MeasureTime frameDescription
A registry of patients undergoing proximal jejunal aspiration for suspected small intestinal bacterial overgrowthTwo yearsA prospective registry will be created for all subjects who are undergoing jejunal aspirate for clinical indications. Private health information will be excluded from the data registry. Data collected for the registry will include: 1. Demographics 2. Patient Assessment of Gastrointestinal Disorders-Symptom Severity Index total and subscale scores 3. Presence of functional gastrointestinal disorders 4. Established risk factors of gram negative small intestinal bacterial overgrowth. 5. Established risk factors of upper respiratory tract small intestinal bacterial overgrowth
The demographics, clinical history, and symptoms in patients with and without SIBOOne dayDemographics 2. Patient Assessment of Gastrointestinal Disorders-Symptom Severity Index total and subscale scores 3. Presence of functional gastrointestinal disorders 4. Established risk factors of gram negative small intestinal bacterial overgrowth. 5\. Established risk factors of upper respiratory tract small intestinal bacterial overgrowth
Characterize the clinical differences between small intestinal bacterial overgrowth by upper respiratory tract bacteria and small intestinal bacterial overgrowth by gram-negative bacilli bacteriaOne dayclinical differences between small intestinal bacterial overgrowth by upper respiratory tract bacteria
Compare the composition between luminal and mucosal bacteria in the proximal small bowelOne dayCompare the results of bacteria species isolated from molecular polymerase chain reaction identification between luminal aspiration samples and mucosa biopsy samples.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORJohn Wo, MD

Indiana University Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 17, 2026